Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Axsome Therapeutics, Inc. News

Bret Jensen: Two Biotechs to Consider

Things are looking up for these drug companies as they make progress with the FDA

4 Biotech Stocks That Could Be Takeover Targets

Even if biotech companies like TG Therapeutics and Clovis Oncology don’t get bought out, they’re still attractive on a standalone basis.

Top Biotech Stocks to Buy for 2021

Here are the biotech stocks to buy that we think will see magnified growth over the coming year. Real Money writer Bret Jensen reveals his top picks.

Immunomedics, Scientific Games: 5 Top Gainers for Monday

Immunomedics, Scientific Games, Axsome Therapeutics, Seattle Genetics and Vaxart are some of the top gainers for Monday.

Axsome Therapeutics Drug Trial Shows Eased Agitation in Alzheimer's Patients

Axsome's treatment 'rapidly improved agitation symptoms,' the company says. About 70% of Alzheimer's patients experience agitation.

Breaking News

The Good Times Are Over for Startups

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.